Latest Government Funding News

Ardea Resources delays the final report for its Kalgoorlie Nickel Project’s Goongarrie Hub DFS beyond June 2026 while initiating a new scandium scoping study, maintaining strong government backing and consortium funding.

Pioneer Minerals has reopened the historic Springfield Mine Road, enabling vehicle access to its North Pine Project in Idaho and slashing exploration costs. This milestone sets the stage for accelerated fieldwork targeting tungsten, gold, and gallium.

Nova Minerals has secured New South Wales Supreme Court approval for its schemes of arrangement, paving the way for its US holding company to take control and triggering ASX delisting and NYSE admission.

Pure Resources has appointed retired US Navy Vice Admiral Jeff Trussler to its advisory board, aiming to fast-track US government funding and integration of its advanced materials into defence supply chains.

Killi Resources has significantly extended the King Louie Breccia gold-copper-molybdenum anomaly at its Mt Rawdon West Project, setting the stage for imminent drill testing backed by government funding.

TruScreen Group reported a 42% increase in FY2026 sales driven by new market entries including India and Indonesia, alongside launching a large-scale cervical cancer screening program in Vietnam and submitting major UNITAID proposals.

Green Cross Health lifted net profit by 28% to NZD 20.4 million in FY26, driven by stronger medical funding and pharmacy revenue growth, while preparing to launch a new Primary Health Organisation.

ReadCloud Limited’s 1H26 results reveal robust growth in school-focused businesses, with cash receipts up 22% and operating cash flow rising 10%, positioning the company to outperform its FY26 earnings guidance.

International Graphite has secured a building permit to start earthworks at its Collie Micronising Facility, unlocking further government funding and keeping the project on track for completion in mid-2027.

Antares Metals (ASX: AM5) reports exceptional surface gold grades up to 41.7 g/t at its Quinns project in WA, revealing three priority drill targets and fast-tracking maiden drilling plans.

Island Pharmaceuticals has appointed Raymond Taylor, a former BioCryst executive with deep Galidesivir expertise and US government funding experience, to accelerate development and procurement efforts for its broad-spectrum antiviral amid rising viral threats.

TruScreen Group Limited has kicked off a NZ$2.9 million capital raising combining a NZ$1 million placement and a NZ$1.94 million rights issue to fund its global expansion and regulatory compliance efforts. The company reported a 42% jump in product sales for FY2026 and is targeting major public health programs across 14 countries.